Emma Sangalang's Colleagues at ALX Oncology
Emma Sangalang's Contact Details
HQ
["(353) 161-8000"]
["(353) 161-8000"]
Location
San Francisco,California,United States
San Francisco,California,United States
Company
ALX Oncology
ALX Oncology
Emma Sangalang's Company Details
ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system. ALX Oncology's lead product candidate, evorpacept (also known as ALX148), is a next generation CD47 blocking therapeutic that combines a high-affinity CD47 binding domain with an inactivated, proprietary Fc domain. Evorpacept has demonstrated promising clinical responses across a range of hematologic and solid malignancies in combination with a number of leading anti-cancer agents.
Frequently Asked Questions about Emma Sangalang
Emma Sangalang currently works for ALX Oncology.
Emma Sangalang's role at ALX Oncology is Scientist.
Emma Sangalang's email address is ***@alexotherapeutics.com. To view Emma Sangalang's full email address, please signup to ConnectPlex.
Emma Sangalang works in the Research industry.
Emma Sangalang's colleagues at ALX Oncology are Julie Bacon, Andrew Olson, Adela Hasa-Moreno, Connie Lu, Michael Chang, Steffen P., Hank Stern and others.
Emma Sangalang's phone number is ["(353) 161-8000"]